Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 36,306 | 34,874 | 24,093 | 4,346 | 228 |
| Cost of Goods | 24,050 | 24,205 | 15,754 | 2,649 | 118 |
| Gross Profit | 12,256 | 10,670 | 8,339 | 1,697 | 111 |
| Operating Expenses | 18,533 | 16,686 | 13,878 | 29,346 | 2,669 |
| Operating Income | -6,227 | -5,812 | -4,785 | -27,001 | -2,440 |
| Interest Expense | 0 | 9 | 137 | 39 | 329 |
| Other Income | 273 | 452 | 812 | 529 | -9,668 |
| Pre-tax Income | -5,954 | -5,369 | -4,111 | -26,511 | -12,437 |
| Income Tax | 22 | -235 | 395 | 233 | N/A |
| Net Income Continuous | -5,975 | -5,134 | -4,506 | -26,744 | -12,437 |
| Net Income | $-5,975 | $-5,134 | $-4,506 | $-26,744 | $-12,437 |
| EPS Basic Total Ops | -1.44 | -7.32 | -351.36 | -3,520.00 | -9,520.00 |
| EPS Basic Continuous Ops | -1.44 | -7.32 | -351.35 | -3,523.41 | -9,522.55 |
| EPS Diluted Total Ops | -1.44 | -7.32 | -351.36 | -3,520.00 | -9,520.00 |
| EPS Diluted Continuous Ops | -1.44 | -7.32 | -351.35 | -3,523.41 | -9,522.55 |
| EPS Diluted Before Non-Recurring Items | N/A | -7.32 | -380.00 | -3,520.00 | -9,520.00 |
| EBITDA(a) | $-4,147 | $-5,589 | $-4,636 | $-8,649 | $-2,427 |